{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe kappa‐opioid receptor (OPRK1) is a seven–transmembrane G protein–coupled receptor whose structure and ligand–binding determinants have been elucidated in recent years. Crystallographic studies have revealed its molecular architecture in complex with selective antagonists such as JDTic, outlining key features of the binding pocket and receptor dimerization interfaces that govern ligand affinity and subtype selectivity (for example, see studies reporting the crystal structure, targeted mutagenesis, mapping of water–accessible residues, glycosylation and phosphorylation effects, and analysis of receptor trafficking mediated by accessory proteins like GEC1)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its structural characteristics, OPRK1 signals via multiple intracellular pathways. Activation by endogenous dynorphins or selective ligands modulates downstream effector cascades—including inhibitory G protein signaling, engagement of beta–arrestin mechanisms, and mitogen–activated protein kinase (MAPK) pathways—to produce diverse physiological responses. These include inhibition of striatal dopamine release that contributes to aversive and dysphoric states, regulation of stress responsivity, and modulation of neuroplasticity in fear and reward circuits. Moreover, heterodimerization with other G protein–coupled receptors (for example, with the apelin and orexin receptors) further tunes signal bias and cellular outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic and clinical studies have further underscored a critical role for OPRK1 in modulating the risk for substance–use disorders and in mediating treatment response. Polymorphisms and regulatory variants in the OPRK1 gene have been associated with heroin and alcohol dependence, altered stress–induced craving, and differences in receptor availability as demonstrated by PET imaging. In addition, pharmacogenetic investigations suggest that these genetic variations may affect the efficacy of opioid antagonists in addiction treatment, while transcriptional coordination with its endogenous ligands (such as prodynorphin) and interplay with dopamine receptor genes further contribute to dysphoric states and relapse risk. These findings, together with reports on selective kappa agonists that achieve potent antinociception with reduced dependence liability, highlight OPRK1 as a promising target for novel therapeutic interventions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "20", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shunji Suzuki, Linda F Chuang, Peter Yau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/excr.2002.5638"}], "href": "https://doi.org/10.1006/excr.2002.5638"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12413885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12413885"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jay P McLaughlin, Mei Xu, Ken Mackie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M304022200"}], "href": "https://doi.org/10.1074/jbc.M304022200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12815037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12815037"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Peng Huang, Deborah Steplock, Edward J Weinman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M313366200"}], "href": "https://doi.org/10.1074/jbc.M313366200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15070904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15070904"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Vadim Yuferov, David Fussell, K Steven LaForge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenetics (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00008571-200412000-00002"}], "href": "https://doi.org/10.1097/00008571-200412000-00002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15608558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15608558"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Feng Yan, Philip D Mosier, Richard B Westkaemper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi050490d"}], "href": "https://doi.org/10.1021/bi050490d"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15952771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15952771"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wei Xu, Mercedes Campillo, Leonardo Pardo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi050938a"}], "href": "https://doi.org/10.1021/bi050938a"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16331961"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16331961"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chongguang Chen, Jian-Guo Li, Yong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M509805200"}], "href": "https://doi.org/10.1074/jbc.M509805200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16431922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16431922"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Michael R Bruchas, Tao Yang, Selena Schreiber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M705540200"}], "href": "https://doi.org/10.1074/jbc.M705540200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17702750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17702750"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jian-Guo Li, Chongguang Chen, Lee-Yuan Liu-Chen "}, {"type": "b", "children": [{"type": "t", "text": "N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi700443j"}], "href": "https://doi.org/10.1021/bi700443j"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17711303"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17711303"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Huixian Wu, Daniel Wacker, Mauro Mileni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the human κ-opioid receptor in complex with JDTic."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature10939"}], "href": "https://doi.org/10.1038/nature10939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22437504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22437504"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Eyal Vardy, Philip D Mosier, Kevin J Frankowski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemotype-selective modes of action of κ-opioid receptor agonists."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.515668"}], "href": "https://doi.org/10.1074/jbc.M113.515668"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24121503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24121503"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jennifer M Johnston, Marta Filizola "}, {"type": "b", "children": [{"type": "t", "text": "Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0090694"}], "href": "https://doi.org/10.1371/journal.pone.0090694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24651466"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24651466"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Casey O'Connor, Kate L White, Nathalie Doncescu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1510117112"}], "href": "https://doi.org/10.1073/pnas.1510117112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26372966"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26372966"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Piotr Kupczyk, Adam Reich, Marcin Hołysz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opioid Receptors in Psoriatic Skin: Relationship with Itch."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Derm Venereol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2340/00015555-2595"}], "href": "https://doi.org/10.2340/00015555-2595"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27958613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27958613"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Adrie W Bruijnzeel "}, {"type": "b", "children": [{"type": "t", "text": "kappa-Opioid receptor signaling and brain reward function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res Rev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainresrev.2009.09.008"}], "href": "https://doi.org/10.1016/j.brainresrev.2009.09.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19804796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19804796"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yalin Li, Jing Chen, Bo Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2011.12.012"}], "href": "https://doi.org/10.1016/j.cellsig.2011.12.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22200678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22200678"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Andras Bilkei-Gorzo, Susanne Erk, Britta Schürmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynorphins regulate fear memory: from mice to men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.1034-12.2012"}], "href": "https://doi.org/10.1523/JNEUROSCI.1034-12.2012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22764240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22764240"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jing Chen, Rumin Zhang, Xiaoyu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2015.03.027"}], "href": "https://doi.org/10.1016/j.cellsig.2015.03.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25866368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25866368"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Diana Martinez, Mark Slifstein, David Matuskey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41386-019-0398-4"}], "href": "https://doi.org/10.1038/s41386-019-0398-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31026862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31026862"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "El Wui Loh, Cathy S J Fann, Yuh Terng Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.ALC.0000106303.41755.B8"}], "href": "https://doi.org/10.1097/01.ALC.0000106303.41755.B8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14745298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14745298"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "X Xuei, D Dick, L Flury-Wetherill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the kappa-opioid system with alcohol dependence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4001882"}], "href": "https://doi.org/10.1038/sj.mp.4001882"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16924269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16924269"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Timothy A Vortherms, Philip D Mosier, Richard B Westkaemper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M609264200"}], "href": "https://doi.org/10.1074/jbc.M609264200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17121830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17121830"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "G Gerra, C Leonardi, E Cortese, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.30510"}], "href": "https://doi.org/10.1002/ajmg.b.30510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17373729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17373729"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Joel Gelernter, Ralitza Gueorguieva, Henry R Kranzler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1530-0277.2007.00339.x"}], "href": "https://doi.org/10.1111/j.1530-0277.2007.00339.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17374034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17374034"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "H Zhang, H R Kranzler, B-Z Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4002035"}], "href": "https://doi.org/10.1038/sj.mp.4002035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17622222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17622222"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Howard J Edenberg, Jun Wang, Huijun Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddn068"}], "href": "https://doi.org/10.1093/hmg/ddn068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18319328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18319328"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yi-Min Tao, Qing-Lin Li, Cong-Fen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejphar.2008.02.028"}], "href": "https://doi.org/10.1016/j.ejphar.2008.02.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18353307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18353307"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "O Levran, D Londono, K O'Hara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic susceptibility to heroin addiction: a candidate gene association study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Brain Behav (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1601-183X.2008.00410.x"}], "href": "https://doi.org/10.1111/j.1601-183X.2008.00410.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18518925"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18518925"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Albert J Arias, Stephen Armeli, Joel Gelernter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1530-0277.2008.00735.x"}], "href": "https://doi.org/10.1111/j.1530-0277.2008.00735.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18537939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18537939"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "C-J Huang, H-F Liu, N-Y Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anaesthesia (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2044.2008.05760.x"}], "href": "https://doi.org/10.1111/j.1365-2044.2008.05760.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19032295"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19032295"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Deepak Kumar, Japashish Chakraborty, Sumantra Das "}, {"type": "b", "children": [{"type": "t", "text": "Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prog Neuropsychopharmacol Biol Psychiatry (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pnpbp.2011.10.018"}], "href": "https://doi.org/10.1016/j.pnpbp.2011.10.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22138325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22138325"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Elisha M Wachman, Marie J Hayes, Richard Sherva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variations in opioid receptor genes in neonatal abstinence syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Alcohol Depend (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.drugalcdep.2015.07.001"}], "href": "https://doi.org/10.1016/j.drugalcdep.2015.07.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26233486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26233486"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Pierre-Eric Lutz, Jeffrey A Gross, Sabine K Dhir, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic Regulation of the Kappa Opioid Receptor by Child Abuse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2017.07.012"}], "href": "https://doi.org/10.1016/j.biopsych.2017.07.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28886759"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28886759"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Igor Bazov, Daniil Sarkisyan, Olga Kononenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Neurobiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12035-017-0844-4"}], "href": "https://doi.org/10.1007/s12035-017-0844-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29383684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29383684"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Aishwarya Vijay, Dana Cavallo, Alissa Goldberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41386-018-0199-1"}], "href": "https://doi.org/10.1038/s41386-018-0199-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30188515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30188515"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "David Matuskey, Mark Dias, Mika Naganawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41386-019-0379-7"}], "href": "https://doi.org/10.1038/s41386-019-0379-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30928993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30928993"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Selena S Schattauer, Andrea Bedini, Floyd Summers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA119.009592"}], "href": "https://doi.org/10.1074/jbc.RA119.009592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31575661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31575661"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Kwo Wei David Ho, Margaret R Wallace, Roland Staud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41397-019-0131-z"}], "href": "https://doi.org/10.1038/s41397-019-0131-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31806881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31806881"}]}]}]}